Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A First in Human Study for the Versa Device for Tricuspid Regurgitation

NCT: NCT06368401 · ACTIVE_NOT_RECRUITING

NCT IDNCT06368401
StatusACTIVE_NOT_RECRUITING
Start Date2024-08-05
Completion2032-12-31
SponsorVersa Vascular, Inc (INDUSTRY)
First posted
Last updated

Brief Summary

This study is prospective, non-randomized, single-arm,first in human study to evaluate the safety and feasibility of the Versa Vascular System for intervention in adults with severe tricuspid regurgitation who are not surgical candidates.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑